FiercePharma

Ori's cell and gene platform wins key FDA advanced manufacturing designation

Ori Biotech has lassoed a significant milestone for its space- and cost-efficient cell and gene therapy manufacturing platform. The FDA has granted the company’s IRO platform an Advanced Manufacturing ...
BioSpaceOpinion

Opinion: Automated Manufacturing Will Meet CAR T Demand

Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, ...
PharmExec

The Situation We Faced: Aaron Cowley, CSO, Recipharm Advanced Bio, Discusses Vision to Cut Biomanufacturing Timelines, Transform Continuous Manufacturing

The "Pharmaceutical Current Good Manufacturing Practices (CGMPs) for the 21st Century--A Risk Based Approach" initiative was ...
Business Wire

LumaCyte Launches Laser Force Cytology™ Academy after Training FDA Reviewers

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--LumaCyte, a trailblazer in advanced label-free cellular bioanalytical technology and instrumentation, proudly announces the launch of the Laser Force Cytology™ ...
PharmiWeb

Pharmaceutical Manufacturing Equipment Market by Trends, Dynamic Innovation in Technology Key Players and Forecast to 2029

Global Pharmaceutical Manufacturing Equipment Market OverviewThe global pharmaceutical manufacturing equipment market is on a growth trajectory, projected to expand at a CAGR of 6–8% over the forecast ...

Contract Manufacturing of Medical Devices Global Markets Report 2025-2030: Growth Driven by Aging Populations, Rising Chronic Disease Burden, and OEM Shift Toward ISO- and FDA ...

The global market for contract manufacturing of medical devices is estimated to grow from $96.4 billion in 2025 to reach $155.2 billion by 2030, at a compound annual growth rate (CAGR) of 10% from ...